NCT01951430

Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients

Observational Prospective Multicenter Study to Evaluate the Infective Risk in Myelodysplastic Syndrome Patients: Antimicrobial Prophylaxis and Granulocyte Growth Factors.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 229 (actual)
• Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to observe the number of new cases of infections per population in a given time period and their characteristics in a pathology (myelodysplastic syndrome, MDS)that involves ineffective production (or dysplasia) of a class of blood cells.

Detailed description

The scarcity and the inadequacy of data make impossible the writing of evidence-based recommendations for prevention and management of infections in myelodysplastic syndrome. The aim of this study is to evaluate the incidence and the spectrum of the infections of MDS patients. Will be also evaluated potential risk factors. This study could help the definition of the optimal management of MDS patients in terms of prophylaxis of the infective complications and in terms of the correct administration of growth factors.

Conditions

• Myelodysplastic Syndrome

Interventions

Type	Name	Description
DRUG	Antibiotic and antifungal drugs

Timeline

• Start date: 2014-03-01
• Primary completion: 2020-10-29
• Completion: 2020-10-29
• First posted: 2013-09-26
• Last updated: 2021-09-13

Locations

25 sites across 1 country: Italy